Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Effectiveness and Safety of Generic vs Original Piperacillin/Tazobactam in a Tertiary Hospital
TCTR20250216005Not yet recruiting
- Sponsor
- Siam Pharmaceutical
- Start
- Mar 2025
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of piperacillin + tazobactam in bacterial disease, sponsored by Siam Pharmaceutical. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
piperacillin + tazobactam
03
Conditions
bacterial disease
Beyond the preview
Go deeper on TCTR20250216005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250216005.